CJC-1295: Some studies have suggested that CJC-1295 may increase the risk of headache, gastrointestinal disturbances, and vasodilation symptoms, including facial flushing, sensations of warmth, and temporarily lowered blood pressure
Shifting the schedule by a day or two has no meaningful impact on cycle outcomes
They may improve local signalling
Oral supplementation presents well-documented absorption challenges
For the underlying mechanism and full gene-expression research, see the complete GHK-Cu research guide
De Giorgi R, Ghenciulescu A, Yotter C et al (2025) Glucagon-like peptide-1 receptor agonists for major neurocognitive disorders